查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1588568

全球大麻酚 (CBG) 软糖市场 - 2024-2031

Global Cannabigerol (CBG) Gummies Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023 年，全球大麻醇 (CBG) 软糖市场规模达到 24.7 亿美元，预计到 2031 年将达到 444 亿美元，2024-2031 年预测期间复合年增长率为 43.5%。

大麻醇 (CBG) 软糖是注入大麻醇的耐嚼糖果，大麻醇是大麻植物中发现的一种大麻素，不会产生精神作用。 CBG 通常被称为“所有大麻素之母”，是衍生其他大麻素（例如 CBD（大麻二酚）和 THC（四氢大麻酚））的基础化合物。

大麻酚 (CBG) 软糖的配方含有特定量的 CBG 萃取物以及各种调味剂和甜味剂，使其成为对消费者有吸引力的选择。它们有不同的品种，包括软糖和硬糖，可以使用全谱、广谱或分离形式的大麻素生产。

市场动态：

司机

大麻合法化与产品创新

全球大麻酚（CBG）软糖市场的需求受到多种因素的推动。主要因素之一是大麻合法化和产品创新。大麻的合法化，无论是用于医疗还是娱乐目的，都大大扩大了大麻醇（CBG）等含有大麻素的产品的市场准入和消费者基础。随着越来越多的州和国家将大麻合法化，消费者有更多机会获得更多种类的大麻衍生产品，包括 CBG 软糖。这种可访问性的增加鼓励更多的人探索这些产品，从而促进市场成长。

本公司在 CBG 软糖市场不断创新，以满足消费者对健康产品日益增长的需求。人们对使用天然植物成分而不是人工添加剂的产品更感兴趣。为了满足这项需求，该公司正在使用有机蔗糖、果胶以及螺旋藻和姜黄等来源的天然香料和色素来配製 CBG 软糖。这种向清洁成分的转变对于注重健康的消费者特别有吸引力，他们寻求更自然的方法来体验 CBG 的潜在好处。

此外，合作伙伴关係和合作等关键参与者策略将推动大麻酚（CBG）软糖市场的成长。例如，2022 年 6 月，Cronos Group Inc. 宣布，他们在生产八种培养大麻素的合作中已达到第三个生产力里程碑。利用 Ginkgo 的有机体设计平台，Cronos 成功实现了四氢大麻酚 (THCV) 的生产力目标，THCV 是一种大麻素，据信可以减轻 THC 的食慾刺激作用。获得更多稀有大麻素将增强 Cronos 的创新管道并支持其商业化策略。

限制

高生产成本和监管挑战等因素预计将阻碍市场发展。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 大麻合法化与产品创新
    • 限制
      • 生产成本高
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：按类别

  • 大麻二酚 (CBD) 食用
  • 大麻醇 (CBG)
  • 大麻酚 (CBN)

第 7 章：按口味

  • 覆盆子汁
  • 草莓果汁
  • 樱桃汁
  • 草莓泥
  • 覆盆子粉
  • 其他的

第 8 章：按形式

  • 硬糖
  • 软糖

第 9 章：按申请

  • 消炎剂
  • 神经保护
  • 焦虑和压力管理
  • 睡眠辅助
  • 情绪调节
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Curaleaf Holding Inc.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • The Cronos Group
  • Charlotte's Web, Inc.
  • Rare Cannabinoid Company.
  • Lazarus Naturals Inc.
  • Hemptown Naturals
  • Green Roads LLC
  • Medterra
  • ENDOCA
  • Extract Labs

第 13 章：附录

简介目录
Product Code: PH8705

Overview

The global cannabigerol (CBG) gummies market reached US$ 2.47 billion in 2023 and is expected to reach US$ 44.4 billion by 2031 growing with a CAGR of 43.5% during the forecast period 2024-2031.

Cannabigerol (CBG) gummies are chewy confections that are infused with cannabigerol, a cannabinoid found in the cannabis plant that does not produce psychoactive effects. Often called the "mother of all cannabinoids," CBG serves as a foundational compound from which other cannabinoids, such as CBD (cannabidiol) and THC (tetrahydrocannabinol), are derived.

Cannabigerol (CBG) gummies are formulated to contain a specific amount of CBG extract, along with various flavorings and sweeteners, making them an appealing choice for consumers. They come in different varieties, including soft and hard candies, and can be produced using full-spectrum, broad-spectrum, or isolated forms of cannabinoids.

Market Dynamics: Drivers

Legalization of cannabis and product innovations

The demand for the global cannabigerol (CBG) gummies market is driven by multiple factors. One of the primary factors is the legalization of cannabis and product innovations. The legalization of cannabis, whether for medical or recreational purposes, has significantly expanded the market access and consumer base for products containing cannabinoids like Cannabigerol (CBG). As more states and countries move to legalize cannabis, consumers have greater access to a wider variety of cannabis-derived products, including CBG gummies. This increased accessibility encourages more people to explore these products, contributing to market growth.

Companies are continuously innovating in the CBG gummies market to meet the growing consumer demand for wellness-oriented products. People are more interested in products that utilize natural, plant-based ingredients instead of artificial additives. In response to this demand, companies are formulating CBG gummies with organic cane sugar, fruit pectin, and natural flavors and colors derived from sources like spirulina and turmeric. This shift towards clean ingredients is particularly appealing to health-conscious consumers who seek a more natural approach to experiencing the potential benefits of CBG.

Moreover, key player strategies such as partnerships and collaborations would propel this cannabigerol (CBG) gummies market growth. For instance, in June 2022, Cronos Group Inc. announced that they had reached the third productivity milestone in their collaboration to produce eight cultured cannabinoids. Utilizing Ginkgo's organism design platform, Cronos has successfully met the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid believed to mitigate the appetite-stimulating effects of THC. This access to additional rare cannabinoids will enhance Cronos' innovation pipeline and support its commercialization strategy.

Restraints

Factors such as high production costs, and regulatory challenges, are expected to hamper the market.

Segment Analysis

The global cannabigerol (CBG) gummies market is segmented based on category, flavor, form, application, and region.

The cannabigerol (CBG) segment accounted for approximately 66.4% of the global cannabigerol (CBG) gummies market share

The cannabigerol (CBG) segment is expected to hold the largest market share over the forecast period. Cannabigerol (CBG) gummies are typically made with natural ingredients, including fruit flavors, to enhance their taste and appeal to consumers. Each gummy contains a pre-measured dose of CBG, providing a consistent and convenient method for incorporating this cannabinoid into daily routines.

While CBG shows potential in promoting mental focus, supporting brain health, and fostering relaxation, further research is essential to fully understand its effects and therapeutic possibilities. Consumers should consult healthcare professionals before starting any new supplements or products.

Moreover, key players in the industry introduced innovative product launches that would propel this cannabigerol (CBG) gummies market growth. For instance, in April 2024, Rare Cannabinoid Company launched special 420 deals on its THC Mood Gummies and CBD oils, celebrating the cannabis culture and offering consumers affordable access to high-quality products. This promotion is particularly notable as it aligns with the 420 holiday, recognized in the cannabis community as a day to celebrate and advocate for cannabis use.

The THC Mood Gummies feature a blend of Delta-9-THC, CBG (cannabigerol), and CBD (cannabidiol), creating a unique edible designed to enhance mood while supporting physical wellness. Each gummy aims to provide a balanced experience, combining the euphoric effects of THC with the calming properties of CBG and CBD. This formulation is intended to offer users a natural way to manage stress and discomfort while promoting overall well-being.

Also, in October 2021, Cronos Group Inc. announced the launch of its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy, marking a significant innovation in the cannabis edible market in Canada. This product is notable as it is the first cannabis gummy in Canada to incorporate both THC and cultured cannabigerol (CBG) derived from fermentation processes, rather than directly from the cannabis plant.

The Chill Bliss gummy is designed to provide a balanced experience, delivering 10 mg of THC and 5 mg of CBG per package, which contains two gummies. Available in a Pineapple Starfruit flavor, this product aims to offer consumers a sweet and enjoyable way to experience the effects of these cannabinoids.

Geographical Analysis

North America accounted for approximately 44.2% of the global cannabigerol (CBG) gummies market share

North America region is expected to hold the largest market share over the forecast period owing to the ongoing legalization of cannabis for medical and recreational purposes in numerous states across the U.S. has greatly broadened the market for CBG products. This legal environment enables consumers to access a diverse array of cannabinoid products, including CBG gummies, without the stigma that often accompanies illegal substances.

In this region, as awareness of cannabinoids increases, a growing number of consumers are recognizing the potential benefits of cannabigerol (CBG) gummies. In contrast to more well-known cannabinoids like CBD and THC, CBG is in more demand for its distinctive properties, including anti-inflammatory effects and neuroprotective advantages. This increased awareness is fueling demand for products infused with CBG.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, innovative product launches, and rising customization & personalization of CBG gummies, would propel this cannabigerol (CBG) gummies market growth. For instance, in November 2023, in U.S. Rare Cannabinoid Company, a prominent innovator in the hemp industry, unveiled its innovative product THC + CBG Relief Gummies. This revolutionary edible combines the power of Delta-9-THC, CBG, and CBD, offering consumers a natural solution to support their physical well-being. Each gummy contains a potent blend of 2.5mg Delta-9-THC, 30mg CBG, and 10mg CBD in a delightful green apple flavor, with 30 gummies per bottle. This convenient and enjoyable formulation aims to provide the potential benefits of these cannabinoids for physical wellness.

Similarly, in December 2022, KANHA, a renowned cannabis brand, launched its CBG "Harmony" gummies, which are positioned as a high-end product within the cannabinoid market. Each package contains a total of 300 mg of lab-tested cannabinoids, featuring twice the CBG content compared to competing offerings. This elevated concentration of CBG is intended to provide enhanced therapeutic benefits for consumers interested in this lesser-known cannabinoid.

The Harmony gummies are specifically formulated to promote both mental and physical wellness, utilizing cannabis-derived terpenes that contribute to a more comprehensive effect. Made with real fruit flavors and all-natural ingredients, these gummies reflect KANHA's dedication to quality and consumer safety. Additionally, the incorporation of NANO technology in the formulation improves absorption, allowing effects to be felt as soon as 15 minutes after consumption.

Market Segmentation

By Category

  • Cannabidiol (CBD) Edible
  • Cannabigerol (CBG)
  • Cannabinol (CBN)

By Flavor

  • Raspberry Juice
  • Strawberry Juice
  • Cherry Juice
  • Strawberry Puree
  • Raspberry Powder
  • Others

By Form

  • Hard Candy
  • Soft Candy

By Application

  • Anti-Inflammatory
  • Neuroprotection
  • Anxiety and Stress Management
  • Sleep Aid
  • Mood Regulation
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the cannabigerol (CBG) gummies market include Curaleaf Holding Inc., The Cronos Group, Charlotte's Web, Inc., Rare Cannabinoid Company., Lazarus Naturals Inc., Hemptown Naturals, Green Roads LLC, Medterra, ENDOCA, and Extract Labs among others.

Key Developments

  • In August 2024, nuEra, a prominent cannabis dispensary chain in Illinois, launched its innovative Alchemy Ratio product line, which includes both gummies and vape cartridges. This new series is crafted to provide consumers with a more balanced and therapeutic cannabis experience, delivering targeted relief through a carefully calibrated blend of cannabinoids.

Why Purchase the Report?

  • To visualize the global cannabigerol (CBG) gummies market segmentation based on category, flavor, form, application, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the cannabigerol (CBG) gummies market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global cannabigerol (CBG) gummies market report would provide approximately 70 tables, 67 figures, and 184 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Category
  • 3.2. Snippet by Flavor
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Legalization of Cannabis and Product Innovations
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Category

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 6.1.2. Market Attractiveness Index, By Category
  • 6.2. Cannabidiol (CBD) Edible*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cannabigerol (CBG)
  • 6.4. Cannabinol (CBN)

7. By Flavor

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 7.1.2. Market Attractiveness Index, By Flavor
  • 7.2. Raspberry Juice *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Strawberry Juice
  • 7.4. Cherry Juice
  • 7.5. Strawberry Puree
  • 7.6. Raspberry Powder
  • 7.7. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Hard Candy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Soft Candy

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Anti-Inflammatory*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Neuroprotection
  • 9.4. Anxiety and Stress Management
  • 9.5. Sleep Aid
  • 9.6. Mood Regulation
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Curaleaf Holding Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. The Cronos Group
  • 12.3. Charlotte's Web, Inc.
  • 12.4. Rare Cannabinoid Company.
  • 12.5. Lazarus Naturals Inc.
  • 12.6. Hemptown Naturals
  • 12.7. Green Roads LLC
  • 12.8. Medterra
  • 12.9. ENDOCA
  • 12.10. Extract Labs

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us